Axogen (AXGN) Liabilities and Shareholders Equity (2016 - 2026)
Axogen has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $289.5 million for Q1 2026.
- For Q1 2026, Liabilities and Shareholders Equity rose 47.57% year-over-year to $289.5 million; the TTM value through Mar 2026 reached $933.0 million, up 19.49%, while the annual FY2025 figure was $221.7 million, 8.82% up from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 was $289.5 million at Axogen, up from $221.7 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $289.5 million in Q1 2026 and troughed at $186.5 million in Q1 2024.
- A 5-year average of $203.4 million and a median of $196.1 million in 2022 define the central range for Liabilities and Shareholders Equity.
- Biggest five-year swings in Liabilities and Shareholders Equity: dropped 6.88% in 2022 and later soared 47.57% in 2026.
- Year by year, Liabilities and Shareholders Equity stood at $195.4 million in 2022, then rose by 0.74% to $196.8 million in 2023, then rose by 3.51% to $203.7 million in 2024, then rose by 8.82% to $221.7 million in 2025, then surged by 30.58% to $289.5 million in 2026.
- Business Quant data shows Liabilities and Shareholders Equity for AXGN at $289.5 million in Q1 2026, $221.7 million in Q4 2025, and $216.4 million in Q3 2025.